Bjones2
2 weeks ago
Dang, Paul completes another Merger!!!
He will find PVSP a partner that wants to go public very soon!!!!!
Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
Press Release | 04/09/2025
Lakewood, CO, April 09, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE
KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion
KRTL Holding Group Inc., a diversified international enterprise focused on biotech innovation, regulatory infrastructure, and strategic investment, is pleased to announce the acquisition of Neurogen Brain Balancing, LLC, a California-based neurotechnology company known for its advanced brain balancing therapies and personalized cognitive optimization systems. This transformative acquisition expands KRTL’s presence in the mental wellness space and enhances its position at the intersection of neuroscience, biotechnology, and global healthcare.
This acquisition establishes Neurogen as a subsidiary of KRTL Holding Group Inc., representing a pivotal step in the company’s broader strategy to integrate advanced neurotechnology into its ecosystem and support the growth of scalable mental health solutions.
Under the terms of the transaction, KRTL has acquired 100% of Neurogen’s equity through a stock-based structure that also includes a collaborative profit-sharing agreement. Additional elements of the consideration include KRTL’s commitment to support Neurogen’s entry into new markets and provide FDA-related services to enhance regulatory pathways and strategic growth alignment between the two companies.
“We are thrilled to welcome Neurogen into the KRTL Holding Group family,” said Cesar Herrera, CEO of KRTL Holding Group. “In today’s rapidly evolving global environment, diversification is not just a strategy—it’s a necessity. By bringing Neurogen into our ecosystem, we strengthen our ability to remain agile, resilient, and forward-thinking across multiple sectors. Their innovative work is a natural fit for our mission to invest in businesses that shape the future.”
Neurogen’s proprietary neurotechnology utilizes advanced neuromodulation protocols that support ions ranging from cognitive performance enhancement to stress reduction and post-trauma recovery. The platform is particularly well-positioned to address critical gaps in the continuation of care for patients seeking alternative therapies. By offering non-opioid, non-invasive treatment options with simplified access, the technology aligns with broader healthcare priorities around expanding safe, effective, and accessible behavioral and neurological health interventions.
"This acquisition marks an exciting new chapter for Neurogen. Joining forces with KRTL Holding Group enables us to accelerate our mission of transforming mental health treatment through cutting-edge neurotechnology. With KRTL’s global infrastructure and regulatory expertise, we’re well-positioned to scale our solutions and reach underserved communities worldwide. Together, we aim to expand access to non-invasive, personalized brain health therapies—advancing a new global standard for neurological wellness," said Gregory Gillispie, President of NeuroGen. "The guidance and infrastructure offered by KRTL enhance our ability to grow responsibly while continuing to focus on improving lives through brain balance."
Strategic Integration and Global Expansion Framework
As part of the integration, Neurogen is being incorporated into KRTL’s operational and regulatory infrastructure. These efforts, which include brand alignment across digital channels and investor communications, financial system harmonization, and scalable operational planning, are underway and being informed by both internal leadership and third-party advisors.
KRTL’s internal systems, including its Quality Management System (QMS) and Enterprise Resource Planning (ERP) infrastructure, are currently under expert review. This assessment is aimed at identifying the most effective enhancements to support joint business capabilities and long-term performance.
Further coordination is focused on regulatory and clinical alignment, including FDA-compliant trials
Bjones2
4 weeks ago
PVSP recognized a gain of over $18 MILLION
Fiscal Year 2024 Highlights:
Divestiture of Artizen Corporation: In November 2024, Pervasip completed the divestiture of its wholly owned subsidiary, Artizen Corporation, including Zen Asset Management LLC. The transaction eliminated approximately $28.1 million in liabilities, including $15 million in debt and $7 million in accrued taxes payable.
$18.2 Million Gain on Discontinued Operations: The Company recognized a gain of $18,172,555 related to the divestiture, reported under discontinued operations.
Equity Structure Realigned: Pervasip cancelled 23,250 shares of Series F Preferred Stock and restructured its Series K and L Preferred Stock to support alignment with current insiders and long-term stakeholders.
Convertible Debt Reduction: The Company reduced its outstanding convertible debt from $605,000 to $530,000 and continues to pursue strategic debt reduction and conversion initiatives to strengthen its balance sheet.
Bjones2
4 weeks ago
PVSP New Strategic Shift Announced
PERVASIP CORP. REPORTS FISCAL 2024 RESULTS AND ANNOUNCES STRATEGIC SHIFT TOWARD AGRITECH INNOVATION
Press Release | 04/01/2025
Seattle, WA � March 27, 2025 � Pervasip Corp. (OTC: PVSP), a diversified technology and asset management company focused on sustainable innovations in agriculture, today announced its financial results for the fiscal year ended November 30, 2024, and provided an update on its strategic transformation following a major divestiture.
Fiscal Year 2024 Highlights:
Divestiture of Artizen Corporation: In November 2024, Pervasip completed the divestiture of its wholly owned subsidiary, Artizen Corporation, including Zen Asset Management LLC. The transaction eliminated approximately $28.1 million in liabilities, including $15 million in debt and $7 million in accrued taxes payable.
$18.2 Million Gain on Discontinued Operations: The Company recognized a gain of $18,172,555 related to the divestiture, reported under discontinued operations.
Equity Structure Realigned: Pervasip cancelled 23,250 shares of Series F Preferred Stock and restructured its Series K and L Preferred Stock to support alignment with current insiders and long-term stakeholders.
Convertible Debt Reduction: The Company reduced its outstanding convertible debt from $605,000 to $530,000 and continues to pursue strategic debt reduction and conversion initiatives to strengthen its balance sheet.
Strategic Realignment
In fiscal 2024, Pervasip exited the cannabis industry and transitioned to a singular focus on solutions for the industrial agriculture industry, including clean water, with a focus on the development of AI-powered biological inputs, consulting services and strategies that increase productivity and reduce environmental impact. For more information,visit www.pervasip.net. This strategic pivot leverages proprietary and licensed technologies to drive crop yield improvements, resource efficiency, and sustainable farming outcomes.
âÂ?Â?Fiscal 2024 marked a transformative year for Pervasip,âÂ? said German Burtscher, CEO of Pervasip Corp. âÂ?Â?By eliminating nearly $30 million in liabilities, stabilizing our capital structure, and repositioning the Company around high-impact agritech solutions, weâÂ?Â?ve laid the foundation for long-term growth. Our focus now is on executing our innovation roadmap and forging strategic partnerships to scale our platform.âÂ?Â
Financial Snapshot (Continuing Operations)
Revenues from continuing operations remain minimal as the Company builds its agritech platform.
Operating loss reflects early-stage investment in product development and strategic repositioning.
The Company continues to operate under a going-concern basis and is actively pursuing financing, joint ventures, and licensing opportunities to accelerate growth.
About Pervasip Corp.
Pervasip Corp. (OTC: PVSP) is a technology and asset management company focused on delivering sustainable solutions to the agriculture industry. The Company is developing AI-driven biological inputs and precision farming strategies designed to enhance productivity and reduce environmental impact.
For more information, visit www.pervasip.net.
Forward Looking Statements The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Investor Contact:
Zachary Logan
Pacific Capital Markets LLC
Phone: 858-308-5835
Email: pacificcapitalmarketsllc@gmail.com
Bjones2
4 weeks ago
Paul gets $20 Million for 10 million shares and signs MOU for merger !!!
This guy never quit's, has KRTL smoking!!!
PVSP is his original baby, he will get control and get us rocking again!!
Guy is a highly rated CPA and expert in all aspects of the markets and understand mergers and how to get funding. No comparison with the weed grower that ran us into the ditch. Nobody was willing to loan us money with this guy at the wheel and to be honest the Cannabis market got worst day by day, declining prices, rising taxes, rising inflationary material expenses, illegal competition growing and stealing potential revenue.
Getting $28 Million reduction in Expenses with the divestiture of Artizen was a great move for PVSP.
Come home Paul we need Ya!!!!
Bjones2
1 month ago
Paul delivers KRTL New Market Listing on Upstream
KRTL Holding Group, Inc Approved to Dual List on Upstream
KRTL Holding Group, Inc ("KRTL") today announced its approval to dual list its shares on Upstream, a MERJ Exchange market and global securities trading app. Trading becomes available on Upstream on Wednesday April 2, 2025, at 10:00am ET under the ticker symbol "KRTL".
About Upstream
Upstream, a MERJ Exchange market (https://merj.exchange/), is a global securities trading app. Powered by Horizon's proprietary, transparency-first, matching engine, Upstream allows investors outside of the U.S. to trade securities using just an app. For more information, please visit https://upstream.exchange/. Upstream is currently accepting applications to dual list at https://upstream.exchange/getlisted.
Bjones2
1 month ago
Paul did not hire this Dope, the Founders did.
The Founders Board hired him for his weed experience, which turned out to be a bad choice.
Never understood why he would waste money and time expanding to other states like California, & Oregon, when growers were closing up operations in droves due to oversupply, declining prices, and illegal operation stealing the business.
Really the best thing for PVSP was to get out of the weed business and transfer all that debt, $28 million to Artizen in the Divestiture last year.
New partner and business model will emerge along with new leadership.
Bjones2
1 month ago
$28 million of liabilities from the Company’s balance sheet
It would have taken Artizen revenue of $400 million or more to payoff that $28 million debt. At least we were able to clean up balance sheet and with the next venture it should be much easier to become a profitable company without the debt anchor hanging around our necks.
Paul will get it done, not this pothead dope playing CEO. I ask you would you lend money to this guy, no way LOL
SEATTLE, WASHINGTON, DECEMBER 23, 2024 – Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the
“Company”), a developer of companies and technologies in high value emerging markets, today announced its
divestiture of Artizen Corporation (“Artizen”) and its subsidiary, Zen Asset Management LLC (“ZAM”). The
divestiture eliminates more than $28 million of liabilities from the Company’s balance sheet, including about $15
million in debt and about $7 million in accrued taxes payable. Pervasip retains a 20% stake in Artizen.